Thilo Spruß

4.5k total citations
80 papers, 3.7k citations indexed

About

Thilo Spruß is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Thilo Spruß has authored 80 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 26 papers in Molecular Biology and 24 papers in Organic Chemistry. Recurrent topics in Thilo Spruß's work include Metal complexes synthesis and properties (22 papers), Ferrocene Chemistry and Applications (17 papers) and Virus-based gene therapy research (9 papers). Thilo Spruß is often cited by papers focused on Metal complexes synthesis and properties (22 papers), Ferrocene Chemistry and Applications (17 papers) and Virus-based gene therapy research (9 papers). Thilo Spruß collaborates with scholars based in Germany, United States and Switzerland. Thilo Spruß's co-authors include Günther Bernhardt, Anja‐Katrin Bosserhoff, Armin Buschauer, Thomas Dobner, Michael Nevels, Hans Wolf, Claus Hellerbrand, Gottfried Schmalz, Gert Fricker and David S. Miller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Genetics.

In The Last Decade

Thilo Spruß

80 papers receiving 3.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Thilo Spruß	1.6k	1.4k	560	508	384	80	3.7k
Larry H. Matherly	4.0k 2.5×	1.2k 0.8×	326 0.6×	448 0.9×	514 1.3×	203	7.5k
Eugenio Erba	2.1k 1.4×	1.3k 0.9×	275 0.5×	183 0.4×	785 2.0×	138	4.6k
Alfonso Calvo	2.4k 1.5×	1.5k 1.1×	549 1.0×	281 0.6×	1.0k 2.7×	198	5.0k
Makiko Fujii	3.4k 2.1×	942 0.7×	359 0.6×	220 0.4×	590 1.5×	188	6.2k
Jun Hu	2.2k 1.4×	762 0.5×	578 1.0×	501 1.0×	1.1k 2.8×	207	4.5k
Clay Winterford	2.1k 1.3×	894 0.6×	521 0.9×	270 0.5×	475 1.2×	44	4.3k
Norbert Kartner	4.0k 2.5×	3.2k 2.2×	645 1.2×	365 0.7×	200 0.5×	49	7.7k
Ulrich auf dem Keller	2.7k 1.7×	1.1k 0.8×	216 0.4×	266 0.5×	1.0k 2.6×	92	5.1k
Robert I. Glazer	4.6k 2.9×	1.9k 1.3×	278 0.5×	413 0.8×	886 2.3×	206	7.0k
Qiang Wang	3.0k 1.9×	1.4k 1.0×	532 0.9×	384 0.8×	814 2.1×	191	5.3k

Countries citing papers authored by Thilo Spruß

Since Specialization

Citations

This map shows the geographic impact of Thilo Spruß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thilo Spruß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thilo Spruß more than expected).

Fields of papers citing papers by Thilo Spruß

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thilo Spruß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thilo Spruß. The network helps show where Thilo Spruß may publish in the future.

Co-authorship network of co-authors of Thilo Spruß

This figure shows the co-authorship network connecting the top 25 collaborators of Thilo Spruß. A scholar is included among the top collaborators of Thilo Spruß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thilo Spruß. Thilo Spruß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Dietrich, Peter, Silke Kuphal, Thilo Spruß, Claus Hellerbrand, & Anja‐Katrin Bosserhoff. (2018). MicroRNA‐622 is a novel mediator of tumorigenicity in melanoma by targeting Kirsten rat sarcoma. Pigment Cell & Melanoma Research. 31(5). 614–629. 19 indexed citations

2.

Dietrich, Peter, Silke Kuphal, Thilo Spruß, Claus Hellerbrand, & Anja‐Katrin Bosserhoff. (2017). Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition. Oncogene. 37(7). 897–911. 44 indexed citations

3.

Spruß, Thilo, Kristian Ikenberg, Peter J. Wild, et al.. (2014). Regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma. Carcinogenesis. 35(6). 1407–1415. 39 indexed citations

4.

Amann, Thomas, Frauke Bataille, Thilo Spruß, et al.. (2010). Reduced Expression of Fibroblast Growth Factor Receptor 2IIIb in Hepatocellular Carcinoma Induces a More Aggressive Growth. American Journal Of Pathology. 176(3). 1433–1442. 52 indexed citations

5.

Amann, Thomas, Frauke Bataille, Thilo Spruß, et al.. (2009). Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Science. 100(4). 646–653. 223 indexed citations

6.

Weiser, Barbara, Lukas Prantl, Thomas Schubert, et al.. (2008). In Vivo Development and Long-Term Survival of Engineered Adipose Tissue Depend on In Vitro Precultivation Strategy. Tissue Engineering Part A. 14(2). 275–284. 36 indexed citations

7.

Hellerbrand, Claus, Thomas Amann, Jürgen Schlegel, et al.. (2007). The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma. Gut. 57(2). 243–251. 59 indexed citations

8.

Hacker, Michael C., Christian F. W. Becker, Siegfried Schreiner, et al.. (2006). Biocompatibility and erosion behavior of triglycerides and blends with cholesterol and phospholipids. University of Regensburg Publication Server (University of Regensburg). 2 indexed citations

9.

Bauer, Björn, David S. Miller, Thilo Spruß, et al.. (2002). Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. Journal of Clinical Investigation. 110(9). 1309–1318. 25 indexed citations

10.

Bauer, Björn, David S. Miller, Thilo Spruß, et al.. (2002). Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. Journal of Clinical Investigation. 110(9). 1309–1318. 283 indexed citations

11.

Spruß, Thilo, et al.. (2002). Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenografts. International Journal of Pharmaceutics. 238(1-2). 111–121. 30 indexed citations

12.

Hartmann, Rolf W., Christine Batzl‐Hartmann, Thilo Spruß, et al.. (2001). 1-(2,6-Dichloro-4-hydroxyphenyl)-2-phenylethanes — New Biological Response Modifiers for the Therapy of Breast Cancer. Synthesis and Evaluation of Estrogenic/Antiestrogenic Properties. Archiv der Pharmazie. 334(4). 125–137. 10 indexed citations

13.

Muckenschnabel, I., Günther Bernhardt, Thilo Spruß, & Armin Buschauer. (1998). Pharmacokinetics and tissue distribution of bovine testicular hyaluronidase and vinblastine in mice: an attempt to optimize the mode of adjuvant hyaluronidase administration in cancer chemotherapy. Cancer Letters. 131(1). 71–84. 31 indexed citations

14.

Bernhardt, Günther, Ronald Gust, Herta Reile, et al.. (1992). [1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. Journal of Cancer Research and Clinical Oncology. 118(3). 209–215. 2 indexed citations

15.

Gust, Ronald, et al.. (1992). Evaluation of the Mammary Tumor Inhibiting Properties. Archiv der Pharmazie. 325(2). 113–118. 13 indexed citations

16.

Bernhardt, Günther, Ronald Gust, Herta Reile, et al.. (1992). [1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer. Journal of Cancer Research and Clinical Oncology. 118(3). 201–208. 8 indexed citations

17.

Reile, Herta, Herbert Birnböck, Günther Bernhardt, Thilo Spruß, & Helmut Schönenberger. (1990). Computerized determination of growth kinetic curves and doubling times from cells in microculture. Analytical Biochemistry. 187(2). 262–267. 105 indexed citations

18.

Reile, Herta, Richard Müller, Ronald Gust, et al.. (1990). Tumor-inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes. Journal of Cancer Research and Clinical Oncology. 116(5). 434–438. 19 indexed citations

19.

Gust, Ronald, Thilo Spruß, M. R. Schneider, et al.. (1988). Ring-substituted [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinoma. Journal of Medicinal Chemistry. 31(1). 72–83. 80 indexed citations

20.

Lux, F., et al.. (1987). Determination of platinum and biologically important trace elements in structure-activity relationship studies on platinum-containing anti-cancer drugs. Special procedures for removing phosphorus-32 as well as for the estimation of molybdenum-99 and gold-199. University of Regensburg Publication Server (University of Regensburg). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact